
|Videos|May 8, 2020
Expanding Options for Treatment of CLL Using BTK Inhibitors
Author(s)Targeted Oncology
Jennifer R. Brown, MD, PhD, and Alan Skarbnik, MD, describe the rationale for treating chronic lymphocytic leukemia with BTK inhibition, and explore current trends in data that impact treatment selection.





































